|
May 10
|
Verona Pharma PLC Reports Q1 2024 Earnings: A Detailed Financial and Strategic Overview
|
|
May 10
|
Verona Pharma plc (NASDAQ:VRNA) Q1 2024 Earnings Call Transcript
|
|
May 9
|
Verona Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update
|
|
May 9
|
Verona Pharma Announces $650 Million Strategic Financing with Oaktree and OMERS
|
|
May 2
|
Verona Pharma to Present Additional Analyses of Positive Phase 3 ENHANCE Studies in COPD at ATS 2024
|
|
Apr 25
|
Verona Pharma to Report First Quarter 2024 Financial Results and Provide Corporate Update
|
|
Mar 4
|
Andrew Fisher Joins Verona Pharma as General Counsel
|
|
Mar 1
|
Verona Pharma plc (NASDAQ:VRNA) Q4 2023 Earnings Call Transcript
|
|
Mar 1
|
3 Healthcare Stocks That Have Outperformed Nvidia Since 2022
|
|
Feb 29
|
Verona Pharma PLC Reports Fourth Quarter and Full Year 2023 Financial Results
|
|
Feb 29
|
Verona Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
|
|
Jan 15
|
Verona Pharma plc's (NASDAQ:VRNA) latest 11% decline adds to one-year losses, institutional investors may consider drastic measures
|
|
Jan 2
|
Verona Pharma enters into Debt Facility of up to $400 Million with Oxford Finance and Hercules Capital
|
|
Dec 30
|
3 Stocks That Could Be Monster Winners in 2024
|
|
Dec 26
|
Fluor Corporation and Align Technology have been highlighted as Zacks Bull and Bear of the Day
|
|
Dec 22
|
3 Beaten-Down Biotech Stocks to Buy for a Turnaround in 2024
|